Cargando…

UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer

Immunotherapy significantly improves the prognosis of advanced lung cancer. It has become an important treatment option for advanced lung cancer. However, there remain many limitations in clinical treatment, and only a small portion of patients can benefit from immunotherapy. Our study aimed to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nan, Shen, Jie, Gou, Lanying, Cao, Manming, Ding, Weimin, Luo, Peng, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275990/ https://www.ncbi.nlm.nih.gov/pubmed/35531878 http://dx.doi.org/10.1080/21655979.2022.2069328

Ejemplares similares

High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy
por: Lyu, Qiong, et al.
Publicado: (2021)

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
por: Zhang, Yueming, et al.
Publicado: (2021)

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
por: Hong, Shuo, et al.
Publicado: (2021)

Ube2i deletion in adipocytes causes lipoatrophy in mice
por: Cox, Aaron R., et al.
Publicado: (2021)

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer
por: Li, Man, et al.
Publicado: (2020)

Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration
por: Guan, Rui, et al.
Publicado: (2021)

Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma
por: Zhou, Chaozheng, et al.
Publicado: (2021)

UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2017)

Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives
por: Luo, Wenxin, et al.
Publicado: (2021)

Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression
por: Li, Jianjun, et al.
Publicado: (2023)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition
por: Lyu, Qiong, et al.
Publicado: (2020)

Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer
por: Qin, Yanan, et al.
Publicado: (2020)

Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
por: Sell, Gabrielle L., et al.
Publicado: (2021)

Comparison of the results of open PLIF versus UBE PLIF in lumbar spinal stenosis: postoperative adjacent segment instability is lesser in UBE
por: Li, Xiaobin, et al.
Publicado: (2023)

Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)

The function and clinical relevance of lncRNA UBE2CP3-001 in human gliomas
por: Luo, Zhengxiang, et al.
Publicado: (2018)

The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells
por: Zhang, Shizhen, et al.
Publicado: (2023)

Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer
por: Mei, Lihong, et al.
Publicado: (2023)

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
por: Cao, Kui, et al.
Publicado: (2022)

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

Toxicities of Immunotherapy for Small Cell Lung Cancer
por: Fu, Yang, et al.
Publicado: (2021)

The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer
por: Wang, Yufei, et al.
Publicado: (2021)

A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
por: Xu, Tiantian, et al.
Publicado: (2022)

UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2019)

Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome
por: Berg, Elizabeth L., et al.
Publicado: (2021)

Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
por: Syding, Linn Amanda, et al.
Publicado: (2022)

High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression
por: Shen, Zhihua, et al.
Publicado: (2013)

UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells
por: Luo, Yanyan, et al.
Publicado: (2023)

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity
por: Shi, Yuheng, et al.
Publicado: (2017)

Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans
por: Landers, Miguel, et al.
Publicado: (2005)

The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
por: Jiang, Long, et al.
Publicado: (2021)

Hsa_circ_0092887 targeting miR‐490‐5p/UBE2T promotes paclitaxel resistance in non‐small cell lung cancer
por: Wang, Limei, et al.
Publicado: (2022)

Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma
por: Xu, Feng, et al.
Publicado: (2022)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

Identification of small molecule inhibitors against UBE2C by using docking studies
por: Sabitha, Kesavan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3bm8klamo3nbgln9bpm9aajsqh